1. Yoo EH, Lee SY. Glucose biosensors: an overview of use in clinical practice. Sensors (Basel). 2010; 10:4558–4576. PMID:
22399892.
Article
2. Kim SK, Hahm JR, Kim HS, Kim S, Jung TS, Jung JH, et al. Spurious elevation of glucose concentration during administration of high dose of ascorbic acid in a patient with type 2 diabetes on hemodialysis. Yonsei Med J. 2013; 54:1289–1292. PMID:
23918584.
Article
3. Riley SG, Chess J, Donovan KL, Williams JD. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid. BMJ. 2003; 327:608–609. PMID:
12969932.
Article
4. Moon HW, Kim JY, Kang ES, Chung WS. Interference with the measurement of blood glucose in different systems after intravenous high dose ascorbic acid supplement. Korean J Lab Med. 2005; 25:294–299.
5. Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev. 2008; 108:2482–2505. PMID:
18465900.
Article
6. Kim YB, Seo JY, Lee SY, Park HD. Performance evaluation of glucometer Barozen H based on ISO 15197 standards. Lab Med Online. 2015; 5:6–14.
Article
7. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000; 113:75–86. PMID:
10631860.
Article
8. Ng WY, Tiong CC, Jacob E. Maltose interference-free test strips for blood glucose testing at point-of-care: a laboratory performance evaluation. Diabetes Technol Ther. 2010; 12:889–893. PMID:
20879959.
Article
9. International Organization for Standardization. In vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197. Geneva: ISO;2013(E).
10. Floré KM, Delanghe JR. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int. 2009; 29:377–383. PMID:
19602602.
Article